Here are the most important news, trends and analysis that investors need to start their trading day: 1. Wall Street set to pick up where 2020 left off Traders work on the floor of the NYSE on Dec. 31st, 2020. NYSE U.S. stock futures rose Monday after the Dow Jones …
Read More »UK rolls out AstraZeneca-Oxford vaccine
UK Prime Minister Boris Johnson poses for a photograph with a vial of the AstraZeneca/Oxford University Covid-19 candidate vaccine. WPA Pool | Getty Images News | Getty Images LONDON — The U.K. has started rolling out the coronavirus vaccine developed by AstraZeneca and the University of Oxford, marking another step …
Read More »Doctors criticize UK health officials for changing Pfizer Covid vaccine plan
A nurse prepares to administer the Pfizer-BioNTech COVID-19 vaccine at Guy’s Hospital in London, Britain December 8, 2020. Frank Augstein | Reuters Doctors in the United Kingdom are pushing back on health officials’ decision to change the vaccine schedule on Pfizer’s Covid-19 immunizations, saying it fails to follow the “science.” …
Read More »Oxford researcher says future strains can be protected against
Sir John Bell, a professor at Oxford University in the U.K., told CNBC on Wednesday he was confident that Covid-19 vaccines could be retooled to provide effective protection against future coronavirus mutations. Bell’s comments on “Closing Bell” come as global attention focuses on a strain of the virus widely circulating …
Read More »5 things to know before the stock market opens Wednesday
Here are the most important news, trends and analysis that investors need to start their trading day: 1. McConnell blocks $2,000 stimulus checks Senate Majority Leader Mitch McConnell (R-KY) speaks at a news conference with other Senate Republicans at the U.S. Capitol on December 15, 2020 in Washington, DC. Tom …
Read More »AstraZeneca, Intel, Caterpillar, Alibaba & more
Check out the companies making headlines before the bell: AstraZeneca – Britain became the first country to approve the drug maker’s Covid-19 vaccine, setting the stage for a rollout of millions of doses. The vaccine is not yet approved in the U.S., with the FDA still to review large-scale trials. The …
Read More »Oxford-AstraZeneca Covid vaccine approved by UK regulator
A Brazilian doctor voluntarily receives an injection as part of phase 3 trials of a vaccine developed by the University of Oxford and British pharmaceutical company AstraZeneca, in July 2020. Nelson Almeida | AFP | Getty Images LONDON — The coronavirus vaccine being developed by the University of Oxford and …
Read More »Nikola, Weibo, DoorDash & more
Nikola Corporation rang the Nasdaq Closing Bell remotely from across the world. Source: The Nasdaq Check out the companies making headlines midday on Monday: Nikola — Shares of the electric-vehicle maker rose nearly 6% after a JPMorgan analyst said he sees a “less drama-filled” news flow for the company in …
Read More »Stocks making the biggest moves premarket: Alibaba, AT&T, AstraZeneca, DoorDash, others
These are the stocks posting the largest moves before the bell.
Read More »UK expected to approve Oxford-AstraZeneca Covid vaccine this week
A laboratory technician supervises filling and packaging tests for the large-scale production and supply of the University of Oxfords COVID-19 vaccine candidate, AZD1222, conducted on a high-performance aseptic vial filling line on September 11, 2020 at Catalent in Anagni, Italy. Vincenzo Pinto | AFP | Getty Images LONDON — The …
Read More »Why Covid vaccine is ‘more like a tetanus shot,’ says NIH Director
National Institutes of Health Director Dr. Francis Collins told CNBC that “it was very likely” that the U.S. government is close to a deal with Pfizer for up to an additional 100 million Covid vaccine doses. “It is good news it sounds like it’s very likely,” said Collins. “We’ll have …
Read More »COVAX global Covid vaccine program secures nearly 2 billion doses for UNICEF distribution
A pharmacist prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at UCI Medical Center in Orange, California, U.S., on Wednesday, Dec. 16, 2020. Bing Guan| Bloomberg | Getty Images The global alliance aiming to provide poor nations with coronavirus vaccines said Friday it has supply agreements to provide nearly 2 …
Read More »Cooperation with AstraZeneca a ‘great example’
A picture taken on December 4, 2020 shows the production of Russia’s Gam-COVID-Vac vaccine against the coronavirus. OLGA MALTSEVA | AFP | Getty Images LONDON — Cooperation between vaccine makers will increase in 2021, according to the head of Russia’s sovereign wealth fund, who welcomed the recent announcement of a …
Read More »HHS Secretary Azar says the public will get Covid vaccine ‘by the end of February into March’
Health and Human Services Secretary Alex Azar told “The News with Shepard Smith” that most Americans can expect to get the coronavirus vaccine as soon as late February. “I believe by the end of February, the end of March, of course, depending on the decisions by our governors, but I …
Read More »AstraZeneca to work on vaccine with Russia’s Gamaleya
A laboratory technician supervises filling and packaging tests for the large-scale production and supply of the University of Oxfords COVID-19 vaccine candidate, AZD1222, conducted on a high-performance aseptic vial filling line on September 11, 2020 at Catalent in Anagni, Italy. Vincenzo Pinto | AFP | Getty Images LONDON — British …
Read More »Rich nations accused of hoarding doses
Nurse Paula McMahon (R) prepares a dose of the Pfizer-BioNTech Covid-19 vaccine for Grace Thomson (L) at the Louisa Jordan Hospital in Glasgow on December 8, 2020 as Britain starts is biggest ever vaccination program. Jeff J. Mitchell | AFP | Getty Images LONDON — A coalition of campaigning bodies …
Read More »5 things to know before the stock market opens December 9, 2020
Here’s the most important news, trends and analysis that investors need to start their trading day: 1. Dow set to add to Tuesday’s record close The S&P 500 saw its first close over 3,700 as Wall Street has gotten off to a strong start in December in a continuation of …
Read More »Oxford-AstraZeneca vaccine to immunize the planet ‘more effectively,’ Lancet editor says
Staff at CSL are working in the lab on November 08, 2020 in Melbourne, Australia, where they will begin manufacturing AstraZeneca-Oxford University COVID-19 vaccine. Darrian Traynor | Getty Images LONDON — The Oxford-AstraZeneca coronavirus vaccine has a “distinct comparative advantage” over other leading candidates, according to the editor-in-chief of The …
Read More »What it’s like in Pfizer, Moderna trials
The Pfizer–BioNTech coronavirus vaccine is both safe and effective, according to the U.S. Food and Drug Administration. In a report released Tuesday morning, the FDA indicated that it could greenlight the country’s first Covid-19 inoculation within days. If Pfizer’s shot is granted an emergency use authorization, or EUA, the immunizations …
Read More »Beware of Covid vaccine scams. Don’t get a fake one
Woman holds vials labelled “COVID-19 Coronavirus Vaccine” over dry ice in this illustration taken, December 5, 2020. Dado Ruvic | Illustration | Reuters “I can’t produce enough for the masses,” Johnny T. Stine wrote on Facebook in May, “but in 18 months, when the virus is long gone, everyone will …
Read More »Oxford-AstraZeneca vaccine is safe and effective, researchers
A test tube labelled vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. Dado Ruvic | Reuters LONDON — The coronavirus vaccine developed by British pharmaceuticals giant AstraZeneca, in collaboration with the University of Oxford, is the first to have its late-stage trial results …
Read More »5 things to know before the stock market opens December 8, 2020
Here’s the most important news, trends and analysis that investors need to start their trading day: 1. Dow set to drop for second day after Friday’s record Traders work on the floor of the New York Stock Exchange. NYSE The Dow was set to drop about 100 points at Tuesday’s …
Read More »Bill Gates says six Covid vaccines could be available by spring 2021
Bill Gates, founder of Microsoft and the Bill & Melinda Gates Foundation. Lintao Zhang | Getty Images News | Getty Images SINGAPORE — Bill Gates has predicted there could be as many as half a dozen Covid-19 vaccines approved and ready for distribution by the spring of 2021, as medical …
Read More »UK to rollout Covid vaccine Tuesday
Nurses at the Royal Free Hospital, London, simulate the administration of the Pfizer vaccine to support staff training ahead of the rollout, on December 5, 2020 in London, England. WPA Pool | Getty Images News | Getty Images The U.K. is preparing to administer the first Covid-19 vaccines to the …
Read More »Facebook to remove misinformation about Covid vaccines
Facebook’s logo displayed on a phone screen and keyboard. Jakub Porzycki | NurPhoto via Getty Images Facebook said Thursday it will start removing misinformation about coronavirus vaccines as countries around the world prepare to start rolling them out. Facebook’s policy has been to remove false claims about Covid-19 that it …
Read More »Warp Speed’s supply director urges patience on Covid vaccine
Operation Warp Speed’s director of supply production and distribution put out an estimated timetable on Covid-19 vaccine availability across the United States. In an interview on CNBC’s “The News with Shepard Smith” on Wednesday evening, Lt. Gen. Paul Ostrowski (Ret.) assured that everyone who wants a vaccine would be able …
Read More »WHO says Covid vaccine approval is a first step, demand must be created
Executive Director of the World Health Organization’s (WHO) emergencies program Mike Ryan speaks at a news conference on the novel coronavirus (2019-nCoV) in Geneva, Switzerland. Denis Balibouse | Reuters Approving a coronavirus vaccine is only the first step toward suppressing the pandemic, as countries race to build distribution networks to …
Read More »Dr. Scott Gottlieb sees Covid vaccine in ‘rationing’ mode into the spring
Dr. Scott Gottlieb told CNBC on Wednesday the availability of coronavirus vaccine doses is likely to be limited in the next few months should U.S. regulators grant emergency approval later this month. “We’re going to be in this sort of rationing type of environment for this vaccine probably well into the …
Read More »Roche’s coronavirus antibody test gets emergency use authorization from the U.S.
A healthcare worker performs laboratory tests. Sergei Karpukhin | TASS | Getty Images Roche received emergency use authorization (EUA) from the U.S. Food and Drug Administration for a new test that measures coronavirus antibodies within the blood. The Swiss diagnostics and pharmaceutical giant said Wednesday that the test, called “Elecsys …
Read More »Trump Covid vaccine chief says everyone in U.S. could be immunized by June
A health care worker injects the a syringe of the phase 3 vaccine trial, to a volunteer at the Ankara University Ibni Sina Hospital in Ankara, Turkey on October 27, 2020. This vaccine candidate developed against the novel coronavirus (COVID-19) pandemic by the U.S. Pfizer and German BioNTech company. Dougkan …
Read More »Goldman predicts how quickly Covid-19 vaccines will be rolled out
A health worker injects a person during clinical trials for a Covid-19 vaccine at Research Centers of America in Hollywood, Florida. Eva Marie Uzcategui | Bloomberg | Getty Images Investment bank Goldman Sachs has forecast that more than 70% of people in developed markets will be vaccinated against the coronavirus …
Read More »More data needed on AstraZeneca’s Covid vaccine trials
A test tube labelled vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. Dado Ruvic | Reuters More data will be needed from AstraZeneca’s coronavirus vaccine trials to determine the drug’s safety and efficacy following concerns from experts in the U.S., scientists from the …
Read More »Britain tries to cool AstraZeneca concerns, CEO touts new vaccine trial
A man walks past a sign at an AstraZeneca site in Macclesfield, central England. Phil Noble | Reuters LONDON — Government ministers and experts in Britain have openly backed a coronavirus vaccine from AstraZeneca and Oxford University, after doubts were raised in the U.S. this week. Housing Minister Robert Jenrick …
Read More »AstraZeneca, Oxford defend vaccine trials after questions raised in US
AstraZeneca’s building in Luton, Britain. Tim Ireland | Xinhua News Agency | Getty Images AstraZeneca and the University of Oxford are defending the results and methods used in their phase three vaccine trials on the back of criticism from experts in the U.S., stressing the “highest standards” were used and …
Read More »Challenges Pfizer faces distributing Covid 19 vaccine to the masses
A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020. Dado Ruvic | Reuters A Covid-19 vaccine is expected to be made available to the public in the coming weeks, …
Read More »Cramer calls this stock market ‘the most speculative’ he’s ever seen
Jim Cramer Scott Mlyn | CNBC CNBC’s Jim Cramer said Tuesday that some of the stock gains in the market are “insane,” with investors recently buying certain names from Tesla to Royal Caribbean seemingly without regard for fundamentals or the state of the coronavirus pandemic and holding onto them. “Where …
Read More »Russia to charge less for Covid vaccine and to produce 1 billion doses
A worker wearing personal protective equipment holds a tray containing unlabeled ampoules of the ‘Gam-COVID-Vac’ COVID-19 vaccine, developed by the Gamaleya National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF). Bloomberg | Bloomberg | Getty Images Hot on the heels of positive coronavirus vaccine news …
Read More »5 things to know before the stock market opens November 24, 2020
Here’s the most important news, trends and analysis that investors need to start their trading day: 1. Dow set to continue Monday’s robust rally Dow futures pointed to an over 250 point gain at Tuesday’s open, with the Trump administration approving Joe Biden‘s transition and the president-elect set to pick …
Read More »Citi on when Covid-19 vaccines will result in ‘herd immunity’ globally
A sign on the entrance to a pharmacy reads “Covid-19 Vaccine Not Yet Available” in Burbank, California on Nov. 23, 2020. Robyn Beck | AFP | Getty Images SINGAPORE — With several Covid-19 vaccine candidates showing promising trial outcomes, investors and analysts have turned increasingly optimistic that the pandemic could …
Read More »White House transition could complicate vaccine distribution
A syringe is seen by the logo of Pfizer’s headquarter in Manhattan, New York City, United States on November 19, 2020. Tayfun Coskun | Anadolu Agency | Getty Images CNBC’s Jim Cramer on Monday gave a forecast of how he projects that the complex coronavirus vaccine distribution process will turn …
Read More »Cramer unveils list of ‘return to normalcy’ stocks on vaccine optimism
After Wall Street digested more positive coronavirus vaccine news and investors grew more optimistic on the reopening trade, CNBC’s Jim Cramer on Monday unveiled a list of “return to normalcy” stocks. “I think you have to buy a couple of these vaccine winners on any weakness, although when it comes …
Read More »NRF sees holiday sales up 3.6% to 5.2%, in a ‘strong finish’ to 2020
Consumers begin their Black Friday specials shopping as Macys opens their doors at 5pm on Thanksgiving Day on November 28, 2019 in New York. Bryan R. Smith | AFP | Getty Images Retailers could end up having a strong finish to 2020, despite all of the challenges that the coronavirus …
Read More »AstraZeneca, Snap, Tesla, Roku & more
Check out the companies making headlines midday Monday: AstraZeneca — Shares of British pharmaceutical giant AstraZeneca fell more than 3% after the company said clinical trials showed its coronavirus vaccine has an average efficacy of 70% in preventing the virus. Its competitors Pfizer and Moderna previously said their Covid-19 vaccine …
Read More »Oxford-AstraZeneca Covid vaccine has some advantages over its peers
AstraZeneca’s building in Luton, Britain. Tim Ireland | Xinhua News Agency | Getty Images LONDON — The coronavirus vaccine being developed by AstraZeneca and the University of Oxford was found to be “highly” protective, potentially paving the way for a vaccine that is more affordable and easier to distribute than …
Read More »Regeneron to provide 300,000 doses of Covid treatment for U.S. by early January, CEO says
Regeneron will provide the U.S. with 300,000 doses of its newly authorized Covid-19 antibody treatment by early January, the company’s CEO, Dr. Leonard Schleifer, said Monday. The Food and Drug Administration on Saturday granted an emergency use authorization for the company’s antibody treatment, called REGN-COV2. The experimental therapy was given to President Donald Trump when he contracted …
Read More »5 things to know before the stock market opens November 23, 2020
Here’s the most important news, trends and analysis that investors need to start their trading day: 1. Stock futures rise after positive news on Covid vaccine, treatments 2. AstraZeneca Covid vaccine shows up to 90% efficacy A test tube labelled vaccine is seen in front of AstraZeneca logo in this …
Read More »Oxford-AstraZeneca Covid vaccine shows an average effectiveness of 70%
A test tube labelled vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. Dado Ruvic | Reuters LONDON — British pharmaceutical giant AstraZeneca on Monday said an interim analysis of clinical trials showed its coronavirus vaccine has an average efficacy of 70% in protecting …
Read More »CRISPR scientists claim identified genes that protect against Covid
COVID-19 Coronavirus molecule, March 24, 2020. CDC | API | Gamma-Rapho via Getty Images A team of CRISPR scientists at the New York Genome Center, New York University and Icahn School of Medicine at Mount Sinai say they have identified the genes that can protect human cells against Covid-19, a …
Read More »Covid reinfection ‘highly unlikely’ for at least 6 months: Oxford study
Residents undergo a free rapid antigen nasopharyngeal swab test for Covid-19 at a testing facility set up in a school sports hall, on November 20, 2020 in Bolzano, South Tyrol, Northern Italy. PIERRE TEYSSOT | AFP | Getty Images LONDON — People who have contracted the coronavirus are “highly unlikely” …
Read More »HHS chief says Pfizer is expected to file FDA application for coronavirus vaccine Friday
Vice President Mike Pence listens to US Secretary of Health and Human Services Alex Azar speak during a White House Coronavirus Task Force press briefing in the James S. Brady Briefing Room of the White House on November 19, 2020. Brendan Smialowski | AFP | Getty Images Health and Human …
Read More »Oxford trial chief says Covid vaccine could be ready at a similar time to others
Staff at CSL are seen working in the lab on Nov. 8 in Melbourne, Australia. CSL will begin manufacturing AstraZeneca-Oxford University Covid-19 vaccine from Monday. Darrian Traynor | Getty Images News | Getty Images LONDON — The coronavirus vaccine being developed by the University of Oxford and AstraZeneca could still be …
Read More »5 things to know before the stock market opens November 19, 2020
Here’s the most important news, trends and analysis that investors need to start their trading day: 1. Dow set to extend losing streak to three sessions Dow futures pointed to a decline at Thursday’s open after two straight down sessions for the 30-stock average. The Dow on Monday rallied to …
Read More »Covid vaccines must be a ‘global public good,’ WHO says
A health care worker injects the a syringe of the phase 3 vaccine trial, to a volunteer at the Ankara University Ibni Sina Hospital in Ankara, Turkey on October 27, 2020. This vaccine candidate developed against the novel coronavirus (COVID-19) pandemic by the U.S. Pfizer and German BioNTech company. Dougkan …
Read More »Oxford Covid vaccine prompts immune response among all adults: Study
Brazilian pediatric doctor Monica Levi, one of the volunteers who received the COVID-19 vaccine, works at the Specialized Clinic in Infectious and Parasitic Diseases and Immunizations (CEDIPI), in Sao Paulo, Brazil, on July 24, 2020. The doctor is one of the 5,000 volunteers participating in Brazil of the phase 3 …
Read More »With vaccine near, how to get it to 7.8 billion people
Pfizer and Moderna released positive late-stage trial data this month showing their coronavirus vaccines were highly effective in preventing Covid-19. The news sent stock markets across the world soaring and gave business executives and world leaders some of the first glimmers of hope that they can bring the epidemic under …
Read More »How much they cost, who’s bought them and how they’re stored
A health care worker holds an injection syringe of the phase 3 vaccine trial, developed against the novel coronavirus (COVID-19) pandemic by the U.S. Pfizer and German BioNTech company, at the Ankara University Ibni Sina Hospital in Ankara, Turkey on October 27, 2020. Dogukan Keskinkilic | Anadolu Agency | Getty …
Read More »HHS Secretary Azar says FDA will move ‘as quickly as possible’ to OK Moderna and Pfizer’s vaccines
Alex Azar, secretary of Health and Human Services (HHS), speaks during a news conference at the CDC Roybal Campus in Atlanta, Georgia, U.S., on Wednesday, Oct. 21, 2020. Elijah Nouvelage | Bloomberg | Getty Images The U.S. Food and Drug Administration will move “as quickly as possible” to clear Pfizer …
Read More »5 things to know before the stock market opens November 16, 2020
1. Dow set to jump on more promising Covid-19 vaccine data Dow futures pointed to about a 500 point gain at Monday’s open after Moderna said its preliminary trial data showed its coronavirus vaccine was more than 94% effective. Last Monday’s Pfizer and BioNTech announcement of more than 90% efficacy …
Read More »BioNTech CEO says life could return to normal next winter
Ugur Sahin, CEO of BioNTech. Andreas Arnold | picture alliance | Getty Images LONDON — Daily life may return to normal by next winter, according to one of the creators of the highly-anticipated prospective coronavirus vaccine by Pfizer and BioNTech. Professor Ugur Sahin, co-founder and chief executive of BioNTech, also …
Read More »Biden team to meet with coronavirus vaccine makers this week
President-elect Joe Biden discusses protecting the Affordable Care Act (ACA) and his health care plans during a news conference in Wilmington, Delaware, November 10, 2020. Jonathan Ernst | Reuters President-elect Joe Biden’s coronavirus advisors will meet with the leading drug companies developing coronavirus vaccines this week, Ron Klain, Biden’s newly …
Read More »Emirates working with Pfizer, others on vaccine transport ‘challenge’
An Airbus A380-800 passenger plane of the Emirates Airlines at Moscow’s Domodedovo Airport. Mikhail Tereshchenko | TASS | Getty Images Emirates is working with global pharmaceutical companies, including Pfizer, to address the logistical challenges of distributing coronavirus vaccines, according to Emirates President Tim Clark. “The industry is trying to establish …
Read More »